公开(公告)号：US10985323B2

公开(公告)日：2021-04-20

申请号：US16162203

申请日：2018-10-16

Applicant: CANON KABUSHIKI KAISHA

Inventor： Norifumi Kajimoto ,  Tetsuo Takahashi ,  Koji Ishizuya ,  Itaru Takaya ,  Hirokazu Miyashita ,  Takayuki Ito ,  Hiroaki Sano

IPC: H01L51/00 ,  H01L51/50 ,  H01L51/52 ,  H01L27/32 ,  H01L27/30 ,  C07C211/01 ,  C07C211/43 ,  C07C211/00 ,  C07C211/33 ,  H01L27/146

Abstract: A light-emitting device includes a plurality of organic EL elements. Each of the organic EL elements includes a reflection electrode, a hole transport region, an electron-trapping luminescent layer, and a light extraction electrode in this order. The hole transport region has a sheet resistance of 4.0×107 Ω/sq. or more at a current of 0.1 nA/pixel, and the total thickness of the hole transport region and the electron-trapping luminescent layer is equivalent to an optical path length enabling emission from the electron-trapping luminescent layer to be enhanced.

公开(公告)号：US10800731B2

公开(公告)日：2020-10-13

申请号：US16630293

申请日：2018-07-03

Applicant: NOURYON CHEMICALS INTERNATIONAL B.V.

Inventor： Rens Veneman ,  Antoon Jacob Berend Ten Kate ,  Michiel Jozef Thomas Raaijmakers ,  Eike Nicolas Kantzer ,  Rolf Krister Edvinsson ,  Karl Fredrik Lake ,  Ina Ehlers ,  Slavisa Jovic ,  Hendrik Van Dam ,  Lars Torbjörn Hagberg

IPC: C07C209/00 ,  C07C211/00 ,  C07C209/16 ,  C07D263/20 ,  C07D233/36 ,  C07C211/14

Abstract: A process is provided for preparing ethylene amines of the formula NH2—(C2H4—NH—)pH wherein p is at least 2, or derivatives thereof wherein one or more units —NH—C2H4—NH— are present as a cyclic ethylene urea unit The process includes reacting an ethanolamine-functional compound OH—(C2H4—NH—)qH or HO—(C2H4—NH)q—C2H4—OH wherein q is at least 1, and an amine-functional compound NH2—(C2H4—NH—)rH wherein r is at least 1, in the presence of a carbon oxide delivering agent and water, with a molar ratio of water:carbon oxide delivering agent of from about 0.01:1 to about 2:1.

公开(公告)号：US10693073B2

公开(公告)日：2020-06-23

申请号：US15110308

申请日：2015-01-08

Applicant: LG CHEM, LTD.

Inventor： Jaesoon Bae ,  Jaechol Lee ,  Jiyoung Lee ,  Doowhan Choi

IPC: H01L51/00 ,  C07C69/157 ,  C07C69/612 ,  C07C69/618 ,  C07C69/738 ,  C07C69/42 ,  C07C211/00 ,  C07C69/757 ,  C07C229/42 ,  C07C69/708 ,  C07C69/54 ,  C09K11/65 ,  C07C69/78 ,  C07C33/38 ,  C07C69/716 ,  C07C69/24 ,  C07C69/76 ,  C01B32/152 ,  C07C43/168 ,  C07C53/08 ,  C07C59/84 ,  C07C63/06 ,  C07C63/36 ,  C07C63/44 ,  C07D333/38 ,  H01L51/42 ,  B82Y30/00 ,  B82Y40/00

Abstract: The present specification relates to an organic electronic device including a fullerene derivative.

公开(公告)号：US10676501B2

公开(公告)日：2020-06-09

申请号：US13554930

申请日：2012-07-20

Applicant: Paul B. Savage

Inventor： Paul B. Savage

IPC: A61L27/14 ,  C07J41/00 ,  A61L27/52 ,  A61L27/54 ,  A61L31/14 ,  A61L31/16 ,  A61L27/34 ,  A61L29/08 ,  A61L29/14 ,  A61L29/16 ,  A61L31/10 ,  C07C211/00 ,  A61L27/18 ,  A61L29/04 ,  A61L31/04

Abstract: A hydrogel polymer includes a ceragenin compound. The ceragenin compound has a hydrophobicity/hydrophilicity that produces a release rate in a range of 0.1-100 μg/ml for at least 3 days.

公开(公告)号：US10593996B2

公开(公告)日：2020-03-17

申请号：US15685234

申请日：2017-08-24

Applicant: UChicago Argonne, LLC

Inventor： John T. Vaughey ,  Niya Sa ,  Hao Wang ,  Baris Key

IPC: H01M10/0569 ,  H01M10/0568 ,  H01M10/0567 ,  H01M10/054 ,  C01F5/00 ,  C07C211/00

Abstract: An electrochemical cell includes a high voltage cathode configured to operate at 1.5 volts or greater, an anode including Mg0, and an electrolyte including an at least one organic solvent, at least one magnesium salt, and at least one additive agent including a Lewis base, wherein the electrolyte is halogen-free.

公开(公告)号：US09580381B2

公开(公告)日：2017-02-28

申请号：US14759511

申请日：2013-12-20

Applicant: Sika Technology AG

Inventor： Edis Kasemi ,  Andreas Kramer ,  Ursula Stadelmann ,  Urs Burckhardt

IPC: C07C211/00 ,  C09K3/00 ,  C07C211/27 ,  C07C209/24 ,  C08G59/22 ,  C08G59/50 ,  C08G59/56 ,  C08L63/00

CPC classification number: C07C211/27 ,  C07C209/24 ,  C08G59/223 ,  C08G59/50 ,  C08G59/5033 ,  C08G59/5046 ,  C08G59/56 ,  C08L63/00

Abstract: An amine which can be used in epoxy resin compositions that cure at room temperature. The amine dilutes the composition highly effectively, allows rapid, trouble-free curing, even in cold and damp conditions, and reduces brittleness. The amine is particularly suitable as a constituent of a curing agent for low-emission epoxy resin compositions that cure at room temperature, in particular for floor coverings.

Abstract translation: 可用于在室温下固化的环氧树脂组合物中的胺。 胺可以高效地稀释组合物，即使在寒冷和潮湿的条件下也能快速，无故障地固化，并降低脆性。 该胺特别适用于在室温下固化的低排放环氧树脂组合物的固化剂的组分，特别是用于地板覆盖物。

公开(公告)号：US09522888B2

公开(公告)日：2016-12-20

申请号：US14831439

申请日：2015-08-20

Applicant: BRISTOL-MYERS SQUIBB COMPANY

Inventor： Alaric J. Dyckman ,  T. G. Murali Dhar ,  Hai-Yun Xiao ,  John L. Gilmore ,  Michael G. Yang ,  Zili Xiao ,  David Marcoux

IPC: C07F9/02 ,  C07C211/00 ,  C07D217/24 ,  C07C215/42 ,  C07C217/52 ,  C07C217/58 ,  C07C219/24 ,  C07C233/41 ,  C07C233/65 ,  C07C251/50 ,  C07C251/52 ,  C07C251/54 ,  C07C271/34 ,  C07C317/28 ,  C07C317/32 ,  C07C321/16 ,  C07C321/22 ,  C07C321/28 ,  C07D213/32 ,  C07D213/69 ,  C07D213/70 ,  C07D215/12 ,  C07D231/12 ,  C07D231/20 ,  C07D239/26 ,  C07D241/12 ,  C07D277/24 ,  C07D305/08 ,  C07D309/06 ,  C07D309/12 ,  C07D311/58 ,  C07D311/76 ,  C07D319/20 ,  C07D333/16 ,  C07F7/08 ,  C07F9/117 ,  C07F9/62 ,  C07F9/6503 ,  C07F9/6509 ,  C07F9/655 ,  C07F9/6553 ,  A61K31/135 ,  C07D215/14 ,  C07D241/04 ,  C07C323/29 ,  C07C251/38 ,  C07C251/42 ,  C07C251/44 ,  C07D209/46 ,  C07D213/38 ,  C07C275/26 ,  C07C217/74 ,  C07C323/25 ,  C07C235/46 ,  C07F9/54 ,  C07F9/572 ,  C07F9/09

CPC classification number: A61K31/695 ,  A61K31/135 ,  A61K31/137 ,  A61K31/15 ,  A61K31/165 ,  A61K31/166 ,  A61K31/17 ,  A61K31/222 ,  A61K31/24 ,  A61K31/27 ,  A61K31/337 ,  A61K31/351 ,  A61K31/352 ,  A61K31/381 ,  A61K31/415 ,  A61K31/4174 ,  A61K31/426 ,  A61K31/44 ,  A61K31/4402 ,  A61K31/4406 ,  A61K31/4409 ,  A61K31/47 ,  A61K31/4965 ,  A61K31/505 ,  A61K31/661 ,  C07B2200/05 ,  C07C215/42 ,  C07C217/52 ,  C07C217/58 ,  C07C217/74 ,  C07C219/24 ,  C07C233/41 ,  C07C233/65 ,  C07C235/46 ,  C07C251/38 ,  C07C251/42 ,  C07C251/44 ,  C07C251/50 ,  C07C251/52 ,  C07C251/54 ,  C07C271/34 ,  C07C275/26 ,  C07C317/28 ,  C07C317/32 ,  C07C321/16 ,  C07C321/22 ,  C07C321/28 ,  C07C323/25 ,  C07C323/29 ,  C07C2601/02 ,  C07C2601/04 ,  C07C2601/08 ,  C07C2602/10 ,  C07C2603/74 ,  C07D209/46 ,  C07D213/32 ,  C07D213/38 ,  C07D213/69 ,  C07D213/70 ,  C07D215/12 ,  C07D215/14 ,  C07D217/24 ,  C07D231/12 ,  C07D231/20 ,  C07D239/26 ,  C07D241/04 ,  C07D241/12 ,  C07D277/24 ,  C07D305/08 ,  C07D309/06 ,  C07D309/12 ,  C07D311/58 ,  C07D311/76 ,  C07D319/20 ,  C07D333/16 ,  C07F7/081 ,  C07F9/091 ,  C07F9/117 ,  C07F9/5442 ,  C07F9/5728 ,  C07F9/62 ,  C07F9/65031 ,  C07F9/650952 ,  C07F9/65522 ,  C07F9/655345

Abstract: Disclosed are compounds of Formulas (I), (II), (III), (IV), and (V): and/or a salt thereof, wherein R1 is —OH or —OP(O)(OH)2, and X1, X2, X3, R2, R2a, Ra, Rb, and Rc are defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.

Abstract translation: 和/或其盐，其中R1是-OH或-OP（O）（OH）2，X1，X2，X3，R2，R2a，Ra，Rb和Rc在本文中定义。 还公开了使用这种化合物作为G蛋白偶联受体S1P1的选择性激动剂的方法，以及包含这些化合物的药物组合物。 这些化合物可用于治疗，预防或减缓各种治疗领域（例如自身免疫疾病和血管疾病）中的疾病或病症的进展。

公开(公告)号：US09499462B2

公开(公告)日：2016-11-22

申请号：US13983430

申请日：2012-02-01

Applicant: Gilbert M. Rishton ,  Susan Catalano

Inventor： Gilbert M. Rishton ,  Susan Catalano

IPC: C07C211/00 ,  C07C33/20 ,  C07C33/14 ,  C07C33/26 ,  C07C33/30 ,  C07C215/26 ,  C07C215/28 ,  C07C211/27

CPC classification number: C07C33/20 ,  C07B2200/07 ,  C07C33/14 ,  C07C33/26 ,  C07C33/30 ,  C07C211/27 ,  C07C215/26 ,  C07C215/28 ,  C07C2601/16

Abstract: Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods for treatment, inhibition, and/or abatement of cognitive decline and/or Alzheimer's disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds/compositions of the invention.

Abstract translation: 提供了用于治疗认知衰退的中枢神经系统药物候选物的化合物，更具体地说是阿尔茨海默氏病。 还提供了用本发明的化合物或药学上可接受的盐治疗，抑制和/或减轻认知衰退和/或阿尔茨海默病的方法。 还提供了制备本发明的化合物/组合物的方法。

公开(公告)号：US20160323935A9

公开(公告)日：2016-11-03

申请号：US13410288

申请日：2012-03-01

Applicant: Richard Jarvis

Inventor： Richard Jarvis

IPC: F28D17/00 ,  C01B7/01 ,  C07C31/00 ,  C07F1/10 ,  C07C211/00

CPC classification number: H05B1/0213 ,  A01N25/34 ,  C09K5/14 ,  A01N59/16 ,  A01N59/20

Abstract: Systems and methods for controlling the temperature of items such as a sample in a vessel or a specimen, in a thermal bath using thermally efficient pellets as the thermal media. The pellets are typically oblong metallic or oblong metallic-coated pellets with rounded edges, a hardened surface, a smooth polished finish, and characteristics that enable efficient thermal communication between the bath's thermal source, the pellets, and the items that are inserted into the mass of pellets. Further, the pellets are dry and moisture and gas impermeable, and they resist microbial growth and are readily decontaminated by several methods including applying an antimicrobial compound to the pellets. The thermal source is controlled to achieve the desired temperature of the items inserted into the pellets.

Abstract translation: 用于使用热效能粒料作为热介质在热浴中控制诸如容器或样品中的样品的物体的温度的系统和方法。 颗粒通常为椭圆形金属或长方形金属涂层的具有圆形边缘的颗粒，硬化表面，光滑的抛光表面，以及使得浴的热源，颗粒和插入质量的物品之间能够有效热连通的特征 的颗粒。 此外，颗粒是干燥和湿气和气体不渗透的，并且它们抵抗微生物生长，并且通过几种方法容易地去污，包括向颗粒施加抗微生物化合物。 控制热源以达到插入颗粒中的物品的期望温度。

公开(公告)号：US09458480B2

公开(公告)日：2016-10-04

申请号：US13730612

申请日：2012-12-28

Applicant: GENOMATICA, INC.

Inventor： Mark J. Burk ,  Anthony P. Burgard ,  Robin E. Osterhout ,  Priti Pharkya

IPC: C08G69/10 ,  C12P17/12 ,  C12P13/00 ,  C12N1/00 ,  C12N1/20 ,  C08G69/26 ,  C08G73/00 ,  C07C205/00 ,  C07C211/00 ,  C12N1/38 ,  C12N15/52 ,  C12P7/40 ,  C12P7/44 ,  C12P13/02 ,  C12P17/10

CPC classification number: C12P17/10 ,  C12N1/38 ,  C12N15/52 ,  C12P7/40 ,  C12P7/44 ,  C12P13/001 ,  C12P13/005 ,  C12P13/02 ,  C12P17/12

Abstract: The invention provides a non-naturally occurring microbial organism having a 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in the respective 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway. The invention additionally provides a method for producing 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid. The method can include culturing a 6-aminocaproic acid, caprolactam or hexametheylenediamine producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding a 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway enzyme in a sufficient amount to produce the respective product, under conditions and for a sufficient period of time to produce 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid.